HCWB
HCW Biologics Inc.
Key Financials
Operating Income
$-13162510
↑ 55.4%
Net Income
$-7959709
↑ 73.5%
Gross Profit
$10846
↓ 98.9%
Revenue
$4.1M
N/A
Total Assets
$24.5M
↓ 18.9%
EPS (Diluted)
$-10.63
↓ 1280.5%
Shareholders' Equity
$2.8M
↑ 140.8%
Total Liabilities
$21.8M
↓ 41.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | HCWB |
| Company Name | HCW Biologics Inc. |
| CIK | 1828673 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 954-842-2024 |